🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-01-01
Trial ID
NCT04767009
Treatments Being Tested
The goal of this prospective study is to explore the safety and preliminary...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-01-15
Trial ID
NCT06775743
Treatments Being Tested
Study to determine the best dose of stereotactic body radiation therapy (SB...
Status
Completed
Location
University of Chicago Medical Center
Start Date
2018-03-15
Trial ID
NCT03431948
Treatments Being Tested
According to literature reports, about 16.3%-19% of newly diagnosed NSCLC p...
Status
Unknown
Location
Chongqing University Cancer Hospital
Start Date
2021-03-01
Trial ID
NCT04905550
This is an open-label, single-arm, Phase II investigator-initiated trial of...
Status
Unknown
Location
The Second Affiliated Hospital of SchoowUniversity
Start Date
2023-04-01
Trial ID
NCT05790447
Treatments Being Tested
Patients with small cell lung cancer that had metastatic lesions after been...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-09
Trial ID
NCT02542137
Treatments Being Tested
Etoposide-cisplatin/ -carboplatin in combination with PD-L1 inhibitor for 4...
Status
Completed
Location
Hunan cancer hospital
Start Date
2020-06-01
Trial ID
NCT04636762
Treatments Being Tested
The incidence of brain metastasis of Her2-negative breast cancer is high, w...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-06-15
Trial ID
NCT06462079
Treatments Being Tested
This is a prospective, single-arm, single-center Phase II clinical study. I...
Status
Not Yet Recruiting
Location
Xinxiang Li
Start Date
2024-11-01
Trial ID
NCT06593548
Treatments Being Tested
Stereotactic radiotherapy (SRT) is a newer type of focused radiation therap...
Status
Completed
Location
Tom Baker Cancer Centre
Start Date
2014-05
Trial ID
NCT02019576
Treatments Being Tested